Posttreatment complications of early-stage prostate cancer patients: Brachytherapy versus three-dimensional conformal radiation therapy

Cancer Journal

Volumn 11, Issue 2, 2005, Pages 122-132

  Tsui, Grace ^a   Gillan, Caitlin ^b   Pond, Gregory ^a   Catton, Charles ^a   Crook, Juanita ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b The Michener Institute for Applied Health Sciences   (Canada)

Author keywords

Conformal radiotherapy; Prostate brachytherapy; Treatment side effects

Indexed keywords

CIPROFLOXACIN; DOXAZOSIN; IODINE 125; PROSTATE SPECIFIC ANTIGEN; SILDENAFIL; TAMSULOSIN; TERAZOSIN;

ADULT; AGED; BRACHYTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; FOLLOW UP; GASTROINTESTINAL TOXICITY; GLEASON SCORE; HUMAN; INTERMETHOD COMPARISON; INTERMITTENT CATHETERIZATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; REVIEW; SEXUAL FUNCTION; TRANSURETHRAL RESECTION; URINARY DYSFUNCTION; ARTICLE; BLADDER DISEASE; COLON DISEASE; COMPARATIVE STUDY; IMPOTENCE; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; RISK ASSESSMENT; TIME;

AGED; BRACHYTHERAPY; COLONIC DISEASES; FOLLOW-UP STUDIES; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATIC NEOPLASMS; RADIOTHERAPY, CONFORMAL; RISK ASSESSMENT; TIME FACTORS; URINARY BLADDER DISEASES;

EID: 33749558983     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200503000-00007     Document Type: Review

References (19)

1. Potosky AL, Miller BA, Albertsen PC et al. The role of increasing detection in the rising incidence of prostate cancer. JAMA 1995;273:548-552.
2. Battermann JJ. Introduction. A symposium: brachytherapy for localized prostate cancer. Radiother Oncol 2000;57:249-250.
3. Beyer DC, Brachman DG. Failure free survival following brachytherapy alone for prostate cancer: comparison with external beam radiotherapy. Radiother Oncol 2000;57:263-267.
4. Beyer DC. The evolving role of prostate brachytherapy. Cancer Control 2001;8:163-170.
5. Zelefsky MJ, Wallner KE, Ling CC et al. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol 1999;17:517-522.
6. Zelefsky MJ, Cowen D, Fuks Z et al. Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer 1999;85: 2460-2468.
7. Denis LJ. The role of active treatment in early prostate cancer. Radiother Oncol 2000;57:251-258.
8. Prestidge BR, Hoak DC, Grimm PD et al. Posttreatment biopsy results following interstitial brachytherapy in early-stage prostate cancer. Int J Radiat Oncol Biol Phys 1997;37:31-39.
9. Butler WM, Merrick GS, Lief JH et al. Comparison of seed loading approaches in prostate brachytherapy. Med Phys 2000;27:381-392.
10. Merrick GS, Butler WM, Dorsey AT et al. Prostatic conformal brachytherapy: 125I/103Pd postoperative dosimetric analysis. Radiat Oncol Invest 1997;5:305-313.
11. Nath R, Anderson LL, Luxton G et al. Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine. Med Phys 1995;22:209-234.
12. Crook JM, Raymond Y, Salhani D et al. Prostate motion during standard radiotherapy as assessed by fiducial markers. Radiother Oncol 1995;37:35-42.
13. Hintze J. NCSS and PASS. Number Cruncher Statistical Systems. Kaysville, Utah. http://www.ncss.com.
14. Rodriguez LV, Blander DS, Dorey F et al. Discrepancy in patient and physician perception of patient's quality of life related to urinary symptoms. Urology 2003;62:49-53.
15. Henderson A, Ismail AK, Cunningham M et al. Toxicity and early biochemical outcomes from 125iodine prostate brachytherapy in the UK: a prospective study. Clin Oncol (R Coll Radiol) 2004;16:95-104.
16. Hu K, Wallner K. Clinical course of rectal bleeding following I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys 1998;41:263-265.
17. Gelblum DY, Potters L. Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2000;48:119-124.
18. Michalski JM, Purdy JA, Winter K et al. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys 2000;46:391-402.
19. Talcott JA, Clark JA, Stark PC et al. Long-term treatment related complications of brachytherapy for early prostate cancer: a survey of patients previously treated. J Urol 2001;166:494-499.